INVO BIOSCIENCE INC (INVO) Forecast, Price Target & Analyst Ratings

NASDAQ:INVOUS44984F4019

Current stock price

0.833 USD
-0.03 (-2.91%)
At close:
0.825 USD
-0.01 (-0.96%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INVO BIOSCIENCE INC (INVO).

Forecast Snapshot

Consensus Price Target

Price Target
$20.40
+ 2,348.98% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 11, 2024

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$20.40
Upside
+ 2,348.98%
From current price of $0.83 to mean target of $20.40, Based on 6 analyst forecasts
Low
$20.20
Median
$20.40
High
$21.00

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for INVO. The average price target is 20.4 USD. This implies a price increase of 2348.98% is expected in the next year compared to the current price of 0.833.

Analyst Ratings & History

Current Analyst Ratings

INVO Current Analyst RatingINVO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

INVO Historical Analyst RatingsINVO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
INVO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about INVO.
In the previous month the buy percentage consensus was at a similar level.
INVO was analyzed by 6 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-04-13Roth CapitalDowngrade Buy -> Neutral
2022-01-19Maxim GroupInitiate Buy
2021-08-18Roth CapitalMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 11, 2024

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
INVO revenue by date.INVO revenue by date.
4.16M
300.00%
820K
-80.29%
3.021M
268.36%
8.612M
185.11%
21.39M
148.37%
46.227M
116.12%
66.908M
44.74%
94.91M
41.85%
126.72M
33.52%
157M
23.90%
EBITDA
YoY % growth
INVO ebitda by date.INVO ebitda by date.
-5.19M
5.64%
-10.55M
-103.28%
-6.566M
37.76%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
INVO ebit by date.INVO ebit by date.
-5.22M
5.26%
-10.63M
-103.64%
-6.767M
36.34%
-7.302M
-7.91%
-2.659M
63.58%
5.915M
322.44%
15.358M
159.64%
30.651M
99.58%
49.653M
61.99%
67.519M
35.98%
Operating Margin
INVO operating margin by date.INVO operating margin by date.
-125.48%-1,296.34%-224.03%-84.79%-12.43%12.80%22.95%32.29%39.18%43.01%
EPS
YoY % growth
INVO eps by date.INVO eps by date.
-0.67
96.66%
-17.80
-2,548.81%
N/A
97.71%
-0.20
50.00%
0.00
100.00%
N/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

INVO Yearly Revenue VS EstimatesINVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
INVO Yearly EPS VS EstimatesINVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -5 -10 -15 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
152.43%
Revenue Next 5 Year
101.26%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

INVO BIOSCIENCE INC / INVO Forecast FAQ

Can you provide the average price target for INVO BIOSCIENCE INC stock?

6 analysts have analysed INVO and the average price target is 20.4 USD. This implies a price increase of 2348.98% is expected in the next year compared to the current price of 0.833.

When does INVO BIOSCIENCE INC (INVO) report earnings?

INVO BIOSCIENCE INC (INVO) will report earnings on 2024-11-11, after the market close.

How many analysts cover INVO BIOSCIENCE INC (INVO) stock?

The number of analysts covering INVO BIOSCIENCE INC (INVO) is 6.